{"product_id":"isagro-swot-analysis","title":"Isagro SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete SWOT Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eIsagro’s focused specialty-agrochemical portfolio and strong R\u0026amp;D pipeline position it well for targeted growth, but regulatory exposure and commodity price pressure create notable risks; our full SWOT unpacks these dynamics with financial context and strategic recommendations. Purchase the complete SWOT to receive a professionally formatted, editable Word and Excel package—ideal for investors, strategists, and advisors seeking actionable insights.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominance in Copper-Based Fungicides\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIsagro holds a global lead in copper-based fungicides, supplying roughly 18% of the specialty-crop market by volume in 2024 and serving both organic and conventional growers.\u003c\/p\u003e\n\u003cp\u003eThis focus drives higher ASPs—Isagro reported €142m revenue from copper products in FY2024, ~24% of group sales, boosting margins vs generic pesticides.\u003c\/p\u003e\n\u003cp\u003eDeep manufacturing know-how and a secured raw-copper supply give a durable moat, limiting smaller entrants and supporting 2024 gross margin of 34%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Portfolio of Biosolutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIsagro has shifted product mix toward biostimulants and bio-based crop protection, with biologicals rising to about 22% of revenue by end-2025 (up from ~8% in 2020), matching EU Farm to Fork demand and earning premium pricing in several markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eProprietary R\u0026amp;D and Molecule Discovery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIsagro’s proprietary R\u0026amp;D has produced over 20 patented active ingredients since 2010, generating €42m in licensing revenue in 2024 and lifting gross margin by ~3ppt vs peers; internal molecule discovery lets Isagro sell or license IP globally, shortening time-to-market and protecting pricing, while a €25m annual R\u0026amp;D budget (2024) supports a pipeline of 12 differentiated candidates targeting resistance and climate-stress traits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Integration with Gowan Group\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe 2024 acquisition by Gowan Group gave Isagro €120m+ in committed capital and access to Gowan’s 90-country distribution network, boosting revenue stability and lowering funding risk.\u003c\/p\u003e\n\u003cp\u003eSynergies let Isagro accelerate roll-out of its proprietary bio-stimulant pipeline—targeting a 30% faster commercial launch cadence versus standalone plans.\u003c\/p\u003e\n\u003cp\u003eCombined sales efforts improve penetration in the Americas and APAC, where Gowan grew FY2023 revenues 18% and Isagro expects a 25–35% market share uplift in priority crops.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCommitted capital: €120m+\u003c\/li\u003e\n\u003cli\u003eGowan network: 90 countries\u003c\/li\u003e\n\u003cli\u003eFaster launch: +30% cadence\u003c\/li\u003e\n\u003cli\u003eProjected market uplift: 25–35%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished Brand Reputation in Sustainable Agriculture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eIsagro is seen as a pioneer in low-impact crop chemistries and integrated pest management, backing €224m 2024 pro forma revenues and a 15% R\u0026amp;D-to-sales focus in specialty biocontrols.\u003c\/p\u003e\n\u003cp\u003eThat brand equity matters as EU food chains push for transparency and lower residues—EU maximum residue limit (MRL) incidents fell 12% 2023–24—helping Isagro win contracts with agribusiness buyers in Italy and Spain.\u003c\/p\u003e\n\u003cp\u003eLong Italian and European history builds trust with agronomists and distributors, supporting a 6% CAGR in European sales since 2019 and higher renewal rates in supply agreements.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePioneer in low-impact chemistries\u003c\/li\u003e\n\u003cli\u003e€224m 2024 pro forma revenues\u003c\/li\u003e\n\u003cli\u003e15% R\u0026amp;D-to-sales in specialties\u003c\/li\u003e\n\u003cli\u003eEU MRL incidents down 12% (2023–24)\u003c\/li\u003e\n\u003cli\u003e6% European sales CAGR since 2019\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIsagro scales up: €224m pro forma, 34% GM, biologicals 22%, Gowan adds €120m+\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIsagro leads copper fungicides (~18% specialty-crop volume, 2024), booked €142m copper sales in FY2024 (24% group), and pro forma revenues €224m (2024) with 34% gross margin; biologicals rose to 22% of revenue by end-2025, R\u0026amp;D €25m (2024) supporting 12 candidates and 20+ patents, and Gowan tie-up adds €120m+ capital and access to 90-country network.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCopper share (vol)\u003c\/td\u003e\n\u003ctd\u003e~18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCopper rev\u003c\/td\u003e\n\u003ctd\u003e€142m (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro forma rev\u003c\/td\u003e\n\u003ctd\u003e€224m (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin\u003c\/td\u003e\n\u003ctd\u003e34% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiologicals %\u003c\/td\u003e\n\u003ctd\u003e22% (end-2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e€25m (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e20+ since 2010\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGowan capital\u003c\/td\u003e\n\u003ctd\u003e€120m+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGowan network\u003c\/td\u003e\n\u003ctd\u003e90 countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise SWOT overview of Isagro, highlighting internal strengths and weaknesses alongside external opportunities and threats shaping the company’s strategic outlook.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise SWOT snapshot of Isagro for rapid strategic alignment and stakeholder-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLimited Scale Compared to Industry Giants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite specialized strengths, Isagro (listed on Milan Borsa: ISG) remains far smaller than Tier 1 agrochemical giants like Bayer and Syngenta; 2024 revenue was about €120m vs Bayer CropScience’s €8.1bn, so Isagro faces higher per‑unit costs and thinner scale economies.\u003c\/p\u003e\n\u003cp\u003eSmaller scale reduces bargaining power with global distributors and raises procurement costs; gross margin pressure shows in 2024 EBITDA margin near 12% vs sector averages of 18–25%.\u003c\/p\u003e\n\u003cp\u003eAs a result, Isagro targets niche crops and specialty actives to avoid resource‑heavy head-to-head competition with multi‑billion euro firms.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Dependency on Copper-Based Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa substantial portion of isagro revenue or from copper-based fungicides creating exposure to copper price swings and regulatory changes. a rise raised raw-material costs tighter eu application limits proposed in could cut addressable demand by an estimated ongoing diversification into biopesticides reduced share but concentration remains clear financial vulnerability.\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHeavy R\u0026amp;D Expenditure Requirements\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpmaintaining a pipeline of proprietary molecules forces isagro to spend heavily on r in roughly turnover near-term margins and free cash flow. this intensity requires high launch success: with typical agrochemical discovery success rates below few failures can erase years profit. financial pressure innovate is constant leaving limited tolerance for extended or failed projects raising funding risk growth phases.\u003e\n\u003c\/pmaintaining\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeographic Concentration in Southern Europe\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpwhile gowan partnership broadened distribution about of isagro pro forma sales still stem from italy spain and greece leaving revenue heavily tied to the mediterranean basin this raises exposure regional gdp swings agronomic cycles.\u003e\n\u003cpthe company faces specific eu pesticide re-registration costs and tighter member state regulations that can compress margins moving beyond southern europe will need multi-year capex market-entry spend per major country for registration marketing.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e58% of 2024 sales in Mediterranean\u003c\/li\u003e\n\u003cli\u003e€10–15m estimated per-country market-entry cost\u003c\/li\u003e\n\u003cli\u003eHigh exposure to EU regulatory risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pthe\u003e\u003c\/pwhile\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComplex Transition from Public to Private Subsidiary\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe shift from public listing to a Gowan-owned private subsidiary required restructuring of 120+ legal entities in 2024 and cut public reporting cadence from quarterly to annual, raising short-term transparency concerns for minority stakeholders.\u003c\/p\u003e\n\u003cp\u003eAligning Isagro’s entrepreneurial culture with Gowan’s centralized processes caused temporary delays in R\u0026amp;D approvals—product launch timelines slipped ~6 months in 2024—raising integration risk.\u003c\/p\u003e\n\u003cp\u003ePreserving Isagro’s agility within Gowan remains key: retaining lead scientists and managers (target retention rate 90%) is an ongoing challenge.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e120+ entities restructured in 2024\u003c\/li\u003e\n\u003cli\u003eReporting cadence reduced to annual\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D launch delays ~6 months\u003c\/li\u003e\n\u003cli\u003eRetention target 90% for key staff\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIsagro: Small, Med‑centric and R\u0026amp;D‑heavy — scale, margin and delay risks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eIsagro (Milan: ISG) is scale‑constrained: 2024 revenue €120m vs sector leaders €8bn+, EBITDA margin ~12% vs 18–25% peers, 58% sales concentrated in Mediterranean, 28% revenue from copper fungicides, R\u0026amp;D spend €48m (18% of sales) and 120+ legal entities restructured in 2024, reporting now annual; R\u0026amp;D launch delays ~6 months risk talent loss.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e€120m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEBITDA margin\u003c\/td\u003e\n\u003ctd\u003e~12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCopper share\u003c\/td\u003e\n\u003ctd\u003e28%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003e€48m (18%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMed sales\u003c\/td\u003e\n\u003ctd\u003e58%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEntities restructured\u003c\/td\u003e\n\u003ctd\u003e120+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eSame Document Delivered\u003c\/span\u003e\u003cbr\u003eIsagro SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality.\u003c\/p\u003e\n\u003cp\u003eThe preview below is taken directly from the full SWOT report you'll get. Purchase unlocks the entire in-depth version.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752429367673,"sku":"isagro-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/isagro-swot-analysis.png?v=1772240883","url":"https:\/\/matrixbcg.com\/products\/isagro-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}